Login / Signup

A SREBF2-dependent gene program drives an immunotolerant dendritic cell population during cancer progression.

Michael P PlebanekYue XueY-Van NguyenNicholas C DeVitoXueying WangAlisha HoltzhausenGeorgia M BeasleyNagendra YarlaBala ThievanthiranBrent A Hanks
Published in: bioRxiv : the preprint server for biology (2023)
The metabolic transcription factor, SREBF2, regulates the development and tolerogenic function of the mregDC population within the tumor microenvironment.
Keyphrases